Recent advances in targeted cancer treatments (see diagram below) and a better understanding of genetics/genomics is creating more viable treatment options for pancreatic cancer patients than ever before.
The Grace Gawler Institute, working closely with its national and international oncology colleagues, clinics and networks, helps patients source newest state-of-the-art treatments in Australia or overseas.
The Institute is also well-positioned to help UK patients with pancreatic cancer via state-of-the-art treatments in Europe.
As a result of her four + decades at the cancer coalface, the institute’s founder/director, Grace Gawler, has developed what is best described as a new paradigm in cancer medicine.
The following page explains how our precision medicine model is disrupting outdated, slow to change, gold standard medical system approaches to Cancer.
So that you are better acquainted with our new paradigm cancer services, please carefully read our front page and associated links.
You might even visit our Stargate Cancer Portal, where you can develop a galactic mindset suitable for your journey into our new paradigm in cancer medicine.
UK patients can visit this page here
More coming soon…